Target intelligence / Profile preview

Nuclear component

Molecular classification
Cellular compartment, Organelle
01

Overview

Nuclear components refer to the collective structural and functional elements found within the eukaryotic cell nucleus, including genomic DNA, various RNA species, histones, and regulatory proteins (Source: Molecular Biology of the Cell). These components are essential for fundamental biological processes such as gene expression, DNA replication, and repair, which maintain cellular homeostasis and genomic integrity. However, the term Nuclear components is considered too broad and non-specific to be classified as a single therapeutic target in drug discovery (Source: Nature Reviews Drug Discovery). Instead, specific molecules within the nucleus, such as DNA topoisomerases, polymerases, or histone deacetylases, serve as the actual targets for pharmacological intervention, particularly in oncology and inflammatory diseases. In clinical practice, nuclear components are highly significant in the context of autoimmune disorders, where they act as antigens for antinuclear antibodies (ANAs), serving as critical diagnostic markers for conditions like systemic lupus erythematosus (Source: StatPearls, Antinuclear Antibody).

Other names
Nuclear componentsNuclear antigensNucleoplasmNuclear structuresCell nucleus
02

Mechanism of action

Drugs targeting nuclear components typically act by intercalating into DNA, inhibiting nuclear enzymes such as topoisomerases or polymerases, or modulating epigenetic states through histone modification (Source: Nature Reviews Cancer).

03

Biological functions

DNA replicationTranscriptionRNA processingChromatin organizationGenomic maintenance
04

Disease associations

Autoimmune diseaseCancerGenetic disorders
05

Safety considerations

GenotoxicityMyelosuppressionSecondary malignanciesSystemic toxicity
06

Interacting drugs

Doxorubicin

4 more in the full profile.

07

Biomarkers

Antinuclear antibodies (ANA)Anti-dsDNA antibodiesAnti-Smith antibodiesAnti-histone antibodies

Beyond the preview

Go deeper on Nuclear component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call